how to stop taking semaglutide (Wegovy) for Weight Loss: Dosing, Results, and Side Effects What Happens After Stopping Semaglutide?

As of early 2026, multiple Phase 3 trials have reported positive topline results, regulatory submissions have been filed, and the FDA is reviewing orforglipron for an obesity indication with a target action date of April 10, 2026

Important Safety Information for Ozempic (semaglutide) injection Warning: Risk of Thyroid C-Cell Tumors In studies with mice and rats, semaglutide (the active ingredient in Ozempic and Wegovy) caused thyroid tumors, including thyroid cancer

The Global Semaglutide Market is estimated to be valued at USD 28.24 Bn in 2026 and is expected to reach USD 51.95 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033

As discussed in prior summaries 1 , the methodology of these epidemiologic reports is frequently flawed and does not confirm or even support a causal relationship between medicine and adverse event

Theres is a reason for the Ozempic craze largely, the durg works